Nurix Therapeutics, Inc. (NRIX)
15.49
-0.15
(-0.96%)
USD |
NASDAQ |
Feb 18, 16:00
15.75
+0.26
(+1.68%)
After-Hours: 19:22
Nurix Therapeutics Total Assets (Quarterly) : 702.56M for Nov. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Incyte Corp. | 6.971B |
| Madrigal Pharmaceuticals, Inc. | 1.362B |
| SELLAS Life Sciences Group, Inc. | 51.56M |
| Arcturus Therapeutics Holdings, Inc. | 282.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 163.82M |
| Shareholders Equity (Quarterly) | 538.75M |
| Debt to Equity Ratio | 0.1034 |
| Current Ratio | 7.018 |
| Net Debt Paydown Yield | -0.32% |